(Q68146585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

C P Blomqvist

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M Virolainen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

I Elomaa

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

100-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686400

22 September 2019

exact match

0 references

cites work

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy

1 reference

12 December 2020

Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy

1 reference

12 December 2020

A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma

1 reference

12 December 2020

Ifosfamide in experimental tumor systems

1 reference

12 December 2020

Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi-institutional phase II trial

1 reference

12 December 2020

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group

1 reference

12 December 2020

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

12 December 2020

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1 reference

12 December 2020

Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Chemotherapy of sarcoma. A comparison of three regimens

1 reference

12 December 2020

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

12 December 2020

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

12 December 2020

Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.

1 reference

12 December 2020

High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma

1 reference

12 December 2020

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

1 reference

12 December 2020

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Chemotherapy of advanced soft-tissue sarcomas in adults

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1600589%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference